Scientists explain a key difference between the spike-protein molecules generated by the SARS-CoV-2 mRNA vaccine and those the virus induces.
Stanford Medicine researcher Josef Parvizi explores the neural origins of where one's sense of self lives in the brain.
Stanford Medicine experts discuss the past successes and future potential of mRNA as a new type of medicine or treatment.
Researchers have found that oxytocin, commonly known as the "love hormone" may not be crucial for the social behaviors it's known for.
Researchers at Stanford are devising new ways to deliver mRNA to the body to facilitate more potent and accurate treatments and vaccines.
This is Part I in a series that will explore the promise, challenges and future of mRNA. Let's count our blessings. The COVID-19 pandemic, from …
By harnessing an antibody most overlooked, researchers devise a new possible way to stop viruses, even as they evolve.
Researchers are making connections between the role of mucus and human health -- both in the brain and the lungs.
A Stanford Medicine researcher discusses his neuroscience-driven investigation into aging and if it's possible to rejuvenate an aging brain.
Stanford psychiatrist Anna Lembke’s book, Dopamine Nation, explains our brain chemistry's role in modern society's addiction to social media.
Four years after his death, possibly the greatest mystery famed neuroscientist Ben Barres ever sought to solve has become a bit less opaque.
During cardiac surgery, patients’ blood levels of a substance highly predictive of Alzheimer’s disease jumped more than 5-fold.
A Stanford neuroscientist has led the development of a novel brain research tool for understanding diseases of brain development.
Stanford bioengineer, neuroscientist and psychiatrist Karl Deisseroth has written a new book -- and it’s not a ‘science book.’
Stanford Medicine researchers have discovered a drug that could potentially be used to stave off SARS-CoV-2, the virus that causes COVID-19.
Stanford Medicine researchers discover that the virus behind COVID-19 attacks insulin-producing cells in the pancreas.
